Central Laboratories Applications & Studies
-
Eliminating The Guesswork From Critical Decision Making
6/19/2023
By leveraging a unified platform, see how this sponsor was able to overcome the logistical complexities of patient randomization, streamlining, and condensing processes.
-
Global Pharmaceutical Leader Achieves Simplified End User Experience
6/1/2023
Unearth how a European pharmaceutical company was able to power its next-generation clinical research data repository and analytics platform.
-
Long-Term Data Services Partnership Drives Efficiency For A Medical Device Trial Sponsor
5/22/2023
Discover how Abiomed was given access to innovative and comprehensive programming solutions to reduce the need for manual data entry and to enhance the clinical trial database usability and speed.
-
A Successful Full-Service, Randomized Pancreatic Cancer Phase II Trial
5/18/2023
Learn how a clinical-stage biopharmaceutical company was able to reach a unanimous decision after a safety review committee data review meeting to close Phase II and advance to Phase III.
-
Enhancing Clinical Trials By Linking Them To RWD
5/16/2023
Learn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.
-
Emerging Biotech Saves Over $300K On Phase I Oncology Trial
4/24/2023
Discover how one platform was able to provide operational efficiencies, data integrity, and savings, enabling the advancement of a clinical program during economic uncertainty.
-
Using IRT Data To Automate And Optimize Clinical Supply
4/17/2023
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
How To Double High-Performing Site Count In A Priority Indication
3/13/2023
A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.
-
Data Management Solution For A Clinical-Stage Cancer Immunotherapy Study
2/9/2023
Check out the results from a clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.
-
BMS Adopts A New Clinical Data Architecture
2/6/2023
Learn how Bristol Myers Squibb was able to optimize data review processes to streamline and improve access to clinical trial records.